financetom
Business
financetom
/
Business
/
iFabric Swings to Profit in Q3 as Revenue More Than Doubles
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
iFabric Swings to Profit in Q3 as Revenue More Than Doubles
Nov 12, 2025 5:52 AM

08:19 AM EST, 11/12/2025 (MT Newswires) -- iFabric (IFA.TO), a player in technology-enhanced apparel, on Wednesday reported a profit in the third quarter, boosted by a rise in revenue.

For the three-months ended Sept. 30, net earnings after tax attributable to shareholders was $543,802 or $0.018 net income per diluted share compared with a net loss after tax attributable to shareholders of $105,616, or $0.003 net loss per diluted share, a year earlier.

Revenue for the quarter increased to $9 million compared with $4.3 million a year-ago.

"We're entering Q4 with strong momentum and clear line-of-sight to carry that strength across FY2026," said iFabric Chief Executive Hylton Karon. "Even as we invest to support rapid growth, we remain focused on profitable execution, operational excellence, and delivering innovative products that keep iFabric on a compelling upward trajectory."

Shares of the company closed down 3.3% to $1.16 on Tuesday on the Toronto Stock Exchange.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Update: Tesla Under NHTSA Probe Over Delays in Crash Reports
Update: Tesla Under NHTSA Probe Over Delays in Crash Reports
Aug 21, 2025
11:09 AM EDT, 08/21/2025 (MT Newswires) -- (Updates with NHTSA's report throughout the story.) Tesla (TSLA) is facing a US National Highway Traffic Safety Administration's audit query over delays in reporting crashes that took place several months or more before the dates of the reports, the regulator said in a report. The Standing General Order in place at the time...
Correction: Market Chatter: US Exploring Equity Stakes in Chipmakers Receiving CHIPS Act Funds
Correction: Market Chatter: US Exploring Equity Stakes in Chipmakers Receiving CHIPS Act Funds
Aug 21, 2025
11:29 AM EDT, 08/21/2025 (MT Newswires) -- (Corrects story to denote President Donald Trump is the current president.) US Commerce Secretary Howard Lutnick is exploring the possibility of the federal government taking equity stakes in semiconductor companies that receive CHIPS Act funding to build factories in the US, Reuters reported Wednesday, citing sources. The idea expands on an existing plan...
Exclusive-CVS holds off adding Gilead's new HIV prevention shot to drug coverage lists
Exclusive-CVS holds off adding Gilead's new HIV prevention shot to drug coverage lists
Aug 21, 2025
(Reuters) -CVS Health, which runs the largest U.S. pharmacy benefit manager, will not add Gilead Sciences' new HIV prevention drug to its commercial plans for now, a spokesperson told Reuters, despite the medicine's proven effectiveness. CVS based the decision on clinical, financial, and regulatory factors, spokesperson David Whitrap said in an email. It also will not cover Yeztugo under its...
Shattuck Labs Says Investigational New Drug Application for SL-325 in Effect
Shattuck Labs Says Investigational New Drug Application for SL-325 in Effect
Aug 21, 2025
11:12 AM EDT, 08/21/2025 (MT Newswires) -- Shattuck Labs ( STTK ) said Thursday its Investigational New Drug application submitted to the US Food and Drug Administration for SL-325, a blocking antibody to treat inflammatory bowel disease, is in effect. SL-325 showed a favorable safety profile in non-human primate studies. Dosing of healthy volunteers in the company's randomized, double-blind, placebo-controlled...
Copyright 2023-2026 - www.financetom.com All Rights Reserved